- Lexaria and GP Holdings LLC enter into a five-year semi-exclusive licensing agreement
- Lexaria and GP have developed a series of high-performing cannabis beverages with nearly zero unwanted taste and odor
- California cannabis-beverage market is expected to be one of the largest edible product segments
Drug delivery innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced a definitive technology licensing agreement with GP Holdings LLC to empower next-generation performance in high absorption, fast acting cannabis-infused beverages to be developed and sold in California. DehydraTECH™ is LXRP’s edible delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. This revolutionary technology makes it possible to deliver bioactive substances via oral ingestion, eliminating the need for unhealthy practices such as inhalation or the addition of sugars or sweeteners, which are commonly used to mask taste.
LXRP and GP have been working for months to develop a high performing cannabis beverage with nearly zero unwanted cannabis odor or flavor. Together, they have developed products with the complete clarity and transparency of even sparkling beverages. GP has acquired rights to use DehydraTECH™ in a five-year semi-exclusive licensing agreement for beverage applications in California and has acquired matching rights to develop topical skin products using this technology as well. Commencement of operations in GP’s new state-of-the-art bottling factory is expected within the next two quarters.
“The use of DehydraTECH™ triggers a race to the top in the California THC beverage and topicals market through this 5-year license agreement,” LXRP CEO Chris Bunka stated in a news release. “This is another long-term strategic relationship that will give consumers the faster acting and highly potent products they deserve, and class-leading flavor profiles for the beverage segment in particular.”
The semi-exclusive agreement gives LXRP the ability to offer other licensee partners the option of utilizing GP’s formulation and manufacturing expertise to produce cannabis-infused beverages throughout California. With the California cannabis-beverage market anticipated to be one of the largest edible product segments, LXRP is strategically positioned for continued growth within the cannabis industry.
For more information, visit the company’s website at www.LexariaBioscience.com
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
